DMN
Damon Inc. Common StockKey Statistics
About Damon Inc. Common Stock
Damon Inc. (Ticker: DMN) is a forward-looking company in the healthcare diagnostics sector, focused on delivering cutting-edge solutions for disease detection and management. The firm harnesses proprietary technologies to produce a diverse array of diagnostic products, emphasizing improved patient outcomes. Positioned strategically to meet the surging demand for reliable and prompt diagnostic tools, Damon Inc. is backed by a vigorous pipeline of R&D initiatives. As the company expands its product lines and enhances its market reach, it aims to solidify its status as a key player in the ever-evolving healthcare landscape.
Fundamentals
| Revenue (TTM) | 49,520 |
| Gross Profit (TTM) | 28,190 |
| EBITDA | $-8.29M |
| Operating Margin | -6820.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.15 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 84.12 |
| EV/Revenue | 27.04 |
| EV/EBITDA | 0.53 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $2.45B |
| Float | $21.47M |
| % Insiders | 2.43% |
| % Institutions | 0.85% |
Historical Volatility
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on DMN and any ticker you trade — then tracks every position and per-strategy win rate.